LFMD
LifeMD, Inc.NASDAQHealthcare$3.51-1.96%ClosedMarket Cap: $168.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
7.23
P/S
0.73
EV/EBITDA
18.03
DCF Value
$-19.71
FCF Yield
8.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.4%
Operating Margin
-0.6%
Net Margin
-2.6%
ROE
-117.7%
ROA
-8.5%
ROIC
-4.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $46.9M | 81.8% | $-1.1M | $-1.5M | $-0.05 | — |
| FY 2025 | $194.1M | 79.8% | $-7.7M | $-7.1M | $-0.23 | — |
| Q3 2025 | $60.2M | 87.7% | $-2.0M | $-3.8M | $-0.10 | — |
| Q2 2025 | $62.2M | 88.1% | $-906.8K | $-2.1M | $-0.06 | — |
| Q1 2025 | $65.7M | 86.8% | $2.5M | $1.4M | $0.01 | — |
| Q4 2024 | $64.3M | 85.3% | $1.0M | $-106.3K | $-0.02 | — |
| FY 2024 | $212.5M | 88.7% | $-16.1M | $-18.9M | $-0.53 | — |
| Q3 2024 | $53.3M | 90.6% | $-4.0M | $-4.7M | $-0.14 | — |
| Q2 2024 | $50.7M | 90.1% | $-6.3M | $-6.9M | $-0.17 | — |
| Q1 2024 | $44.1M | 89.6% | $-6.2M | $-6.8M | $-0.17 | — |
| Q4 2023 | $44.9M | 88.1% | $-2.2M | $-3.7M | $-0.10 | — |
| FY 2023 | $152.5M | 87.6% | $-14.5M | $-20.6M | $-0.70 | — |